vTv Therapeutics (VTVT) Looks Good: Stock Adds 5.8% in Session
vTv Therapeutics Inc. VTVT was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 251.5% in the past one-month time frame.
The company has seen no changes when it comes to estimate revision over the past -few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
vTv Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
vTv Therapeutics Inc. Price
vTv Therapeutics Inc. Price | vTv Therapeutics Inc. Quote
Investors interested in the Medical - Biomedical and Genetics industry may consider a better-ranked stock like Idera Pharmaceuticals, Inc. IDRA, which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is VTVT going up? Or down? Predict to see what others think:Up or Down
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
vTv Therapeutics Inc. (VTVT) : Free Stock Analysis Report
Idera Pharmaceuticals, Inc. (IDRA) : Free Stock Analysis Report
To read this article on Zacks.com click here.
